Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCHUMANN: Eliapixant vs placebo and elagolix in symptomatic endometriosis
jRCT2031210001Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2021
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of eliapixant in endometriosis (5 arms), sponsored by Bayer. Started Mar 2021; status: completed.
02
Drugs
eliapixant
03
Conditions
endometriosis
Beyond the preview
Go deeper on jRCT2031210001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210001.